Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-21-000251
Filing Date
2021-05-14
Accepted
2021-05-14 14:19:32
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. - FORM 10-Q SEC FILING rtsl-20210331.htm   iXBRL 10-Q 428462
2 SUBSCRIPTION AGREEMENT rtsl_ex107.htm EX-10.7 86434
3 CERTIFICATION rtsl_ex311.htm EX-31.1 6621
4 CERTIFICATION rtsl_ex312.htm EX-31.2 6632
5 CERTIFICATION rtsl_ex321.htm EX-32.1 3478
6 CERTIFICATION rtsl_ex322.htm EX-32.2 3596
12 IMAGE rtsl10q_1.jpg GRAPHIC 5735
  Complete submission text file 0001393905-21-000251.txt   2397464

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtsl-20210331_cal.xml EX-101.CAL 18834
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtsl-20210331_def.xml EX-101.DEF 64939
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rtsl-20210331_lab.xml EX-101.LAB 134455
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtsl-20210331_pre.xml EX-101.PRE 131016
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtsl-20210331.xsd EX-101.SCH 46139
13 EXTRACTED XBRL INSTANCE DOCUMENT rtsl-20210331_htm.xml XML 207515
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

EIN.: 462111820 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55018 | Film No.: 21923705
SIC: 2834 Pharmaceutical Preparations